Related Experiment Video

Updated: May 27, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

[Pulmonary aspergillosis and HIV infection: about two cases]

M El Fane1, A Ouladlahsen, A Bakhatar

  • 1Service des maladies infectieuses, CHU Ibn Rochd, quartier des hôpitaux, Casablanca 20100, Maroc. elfanemouna@gmail.com

Revue De Pneumologie Clinique
|November 8, 2011
PubMed

Insights

Invasive pulmonary aspergillosis is rare in AIDS patients, especially those with low CD4 counts. Early diagnosis via CT scans and antigen detection, followed by Voriconazole treatment, is crucial for improving outcomes.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Invasive pulmonary aspergillosis (IPA) is an uncommon opportunistic infection in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • Risk factors for IPA in AIDS include a CD4 T-lymphocyte count below 50 cells/mm³ and other coexisting conditions.

Observation:

  • Diagnosis of IPA relies on chest computed tomography (CT) scans and isolation of Aspergillus species from bronchoalveolar lavage fluid (BALF).
  • Detection of galactomannan antigen in serum and BALF serves as a valuable complementary diagnostic marker.

Findings:

  • Voriconazole is the recommended first-line antifungal therapy for IPA.
  • Prompt initiation of appropriate antifungal treatment significantly impacts the prognosis, which is often severe.

Implications:

  • This case series highlights the importance of considering IPA in immunocompromised AIDS patients, even when it is unusual.
  • Timely diagnosis and treatment are critical for managing IPA and improving patient survival in this vulnerable population.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...